Search
for
Sort by
Research 151–180 of 1000+
- Determination of Oxymatrine in Human Plasma by HPLC-MS
- What does the research say about androgen use and cerebrovascular events?
- A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma
- A rapid, simple, specific liquid chromatographic–electrospray mass spectrometry method for the determination of finasteride in human plasma and its application to pharmacokinetic study
- Flavonoids and saponins: What have we got or missed?
- Effect of finasteride particle size reduction on its pharmacokinetic, tissue distribution and cellular permeation.
- Discovery of Orally Available Prodrugs of Itaconate and Derivatives
- Topical cyclosporin A treatment in psoriasis and other dermatological diseases: Theoretical and practical aspects
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Selected Traditional Herbs for Alopecia and Hair Health: A Scientific Review
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.
- Determination of Finasteride in Human Plasma by HPLC-MS and Study on the Bioequivalence of Domestic and Import Finasteride Tablets
- Tether-induced tenosynovitis: The importance of an intact skin barrier
- 267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome
- Study on Plasma Concentration and Bioavailability of Wogonin in Beagle's Dogs
- Azathioprine
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Pharmacokinetic Interaction between Finasteride and Terazosin, but not Finasteride and Doxazosin
- Recent advances in drug repositioning and rediscovery for different therapeutic activities utilizing updated technological approaches
- Cytokine Engineering Approaches for Regenerative Medicine
- Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite
- LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- O impacto da COVID-19 no ciclo menstrual: uma perspectiva geral
- Systemic Antifungals
- Meet Our Editor